untitled design

Coronavirus: Pfizer and BioNTech sign agreement with US government to supply 105 million vaccine doses

Pfizer Inc. and BioNTech announced yesterday that they have signed a $ 3.2 billion (€ 3.6 billion) deal with the US government to supply 105 million doses of their COVID-19 vaccine.

The installments are expected to be delivered by the end of the summer.

The deal includes a vaccine adapted to the Omicron variant, and is expected to be licensed, according to Pfizer.

Manufacturers of COVID-19 vaccines, including Pfizer, are developing vaccines targeting the Omicron variant, which dominated the spread of infections last winter, causing a massive increase in cases.

The average installment price provided in the agreement exceeds $ 30 (28.71 euros). This is an increase of more than $ 19.50 (€ 18.66) per installment, paid by the US government in its initial contract with Pfizer.

Some of the adult doses included in this contract will be in single-dose vials, which have higher mass production costs but reduce dose losses from vials already opened for use.

U.S. Food and Drug Administration advisers have proposed a change in the planning of COVID-19 boost doses this fall to combat more recent coronavirus strains.


Source: Capital

You may also like

Get the latest

Stay Informed: Get the Latest Updates and Insights


Most popular